Skip to main content

Metastatic CRPC survival doesn't improve with added bevacizumab: Comment

Publication ,  Journal Article
Armstrong, AJ
Published in: Oncology Report
July 1, 2010

Duke Scholars

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

July 1, 2010

Issue

JULY-AUGUST

Start / End Page

23

Related Subject Headings

  • Oncology & Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J. (2010). Metastatic CRPC survival doesn't improve with added bevacizumab: Comment. Oncology Report, (JULY-AUGUST), 23.
Armstrong, A. J. “Metastatic CRPC survival doesn't improve with added bevacizumab: Comment.” Oncology Report, no. JULY-AUGUST (July 1, 2010): 23.
Armstrong AJ. Metastatic CRPC survival doesn't improve with added bevacizumab: Comment. Oncology Report. 2010 Jul 1;(JULY-AUGUST):23.
Armstrong, A. J. “Metastatic CRPC survival doesn't improve with added bevacizumab: Comment.” Oncology Report, no. JULY-AUGUST, July 2010, p. 23.
Armstrong AJ. Metastatic CRPC survival doesn't improve with added bevacizumab: Comment. Oncology Report. 2010 Jul 1;(JULY-AUGUST):23.

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

July 1, 2010

Issue

JULY-AUGUST

Start / End Page

23

Related Subject Headings

  • Oncology & Carcinogenesis